absci amd news - Search News

AMD invests $20 million in AI drug research

AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

YAHOO!Finance · 2d

Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.

Hosted on MSN · 2d

AMD invests $20 million in AI drug research at Vancouver-based Absci

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies. Absci hopes artificial intelligence will enable it to move faster to develop protein-based medicines called biologics,

GEN1h

StockWatch: Will Expanding to Life Sciences Reverse AMD’s Stock Decline?

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

AMD Shares Slide as HSBC Downgrades Stock Over Nvidia Concerns; Absci Collaboration Announced

Following HSBC downgrading of the semiconductor company's stock, Advanced Micro Devices ( AMD, Financials) shares fell over 5 ...

AbSci’s Strategic Growth Bolstered by AMD Collaboration and Promising Pipeline Advancements

Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on AbSci (ABSI – Research Report) and keeping the price target at ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

AMD invests $20 million in AI drug research

Trending now

Related topics